Retension Pharmaceuticals, Inc. (RTSN) stock
RTSNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 18, 2026
$13.89+2.48 (+21.74%)
Close on Nov 18, 2026Market cap $11.22MP/E –Yield –
Retension Pharmaceuticals total assets
Total assets on the balance sheet at the end of each period.
Retension Pharmaceuticals's total assets was $14.15M at Sep 30, 2026. For fiscal 2025 it was $21.45M.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $21.45M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $14.15M | – |
| Q4 FY2025 | Dec 31, 2025 | $21.45M | – |
See a number that looks wrong?